New Posttranslational Modification Lactylation Brings New Inspiration for the Treatment of Rheumatoid Arthritis

Yue Yang,1,* Jinjie Shi,2,* Jiming Yu,3,* Xin Zhao,1 Ke Zhu,1 Shen Wang,4 Xinwen Zhang,1 Xieyu Zhang,1 Guangcheng Wei,1 Wei Cao1 1Rheumatology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China; 2Graduate School, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 3The Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China; 4Orthopedics Department, Nanjing Integrated Traditional Chinese and Western Medicine Hospital, Nanjing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei Cao, Wangjing Hospital of China Academy of Chinese Medical Sciences, 6 South Central Road, Chaoyang District, Beijing, 100102, People’s Republic of China, Email [email protected]: Lactic acid (LA) is an essential glycolytic metabolite and energy source in the body, which is present in high levels in the synovial fluid of patients with rheumatoid arthritis (RA) and is a reliable indicator for identifying inflammatory arthritis. LA not only acts as an inflammatory amplifier in RA, recent studies have found that novel posttranslational modification (PTM) lactylation mediated by LA may also play a key role in RA. Single-cell sequencing showed that the RA lactylation score of patients with RA was significantly increased, and core lactylation-promoting genes, including NDUFB3, NGLY1, and other genes, were found to be potential biomarkers of RA. More studies have shown that lactylation can regulate genes in various cells, such as fibroblast-like synoviocytes (FLSs) and macrophages, thus playing a special role in the development and occurrence of autoimmune diseases, neurological diseases, and cancer diseases. In this paper, we review the research on lactylation in RA-related cells and mechanisms and bring new insights into the pathogenesis, diagnosis, and treatment of RA.Keywords: lactic acid, lactylation, posttranslational modification, rheumatoid arthritis

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2024-12-01
Primary Topic
Aerospace and Aviation Technology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Posttranslational Modification Lactylation Brings New Inspiration for the Treatment of Rheumatoid Arthritis

SHILAP Revista de lepidopterología
Aerospace and Aviation Technology
article

New Posttranslational Modification Lactylation Brings New Inspiration for the Treatment of Rheumatoid Arthritis

article en

Abstract

Yue Yang,1,* Jinjie Shi,2,* Jiming Yu,3,* Xin Zhao,1 Ke Zhu,1 Shen Wang,4 Xinwen Zhang,1 Xieyu Zhang,1 Guangcheng Wei,1 Wei Cao1 1Rheumatology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China; 2Graduate School, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 3The Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China; 4Orthopedics Department, Nanjing Integrated Traditional Chinese and Western Medicine Hospital, Nanjing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei Cao, Wangjing Hospital of China Academy of Chinese Medical Sciences, 6 South Central Road, Chaoyang District, Beijing, 100102, People’s Republic of China, Email [email protected]: Lactic acid (LA) is an essential glycolytic metabolite and energy source in the body, which is present in high levels in the synovial fluid of patients with rheumatoid arthritis (RA) and is a reliable indicator for identifying inflammatory arthritis. LA not only acts as an inflammatory amplifier in RA, recent studies have found that novel posttranslational modification (PTM) lactylation mediated by LA may also play a key role in RA. Single-cell sequencing showed that the RA lactylation score of patients with RA was significantly increased, and core lactylation-promoting genes, including NDUFB3, NGLY1, and other genes, were found to be potential biomarkers of RA. More studies have shown that lactylation can regulate genes in various cells, such as fibroblast-like synoviocytes (FLSs) and macrophages, thus playing a special role in the development and occurrence of autoimmune diseases, neurological diseases, and cancer diseases. In this paper, we review the research on lactylation in RA-related cells and mechanisms and bring new insights into the pathogenesis, diagnosis, and treatment of RA.Keywords: lactic acid, lactylation, posttranslational modification, rheumatoid arthritis

SHILAP Revista de lepidopterología
Openalex Percentile: Top 25%
Aerospace and Aviation Technology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

New Posttranslational Modification Lactylation Brings New Inspiration for the Treatment of Rheumatoid Arthritis · SHILAP Revista de lepidopterología (2024) | TGRS Research Map | TGRS